Osteoclast-expanded supercharged NK cells perform superior antitumour effector functions

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Natural killer (NK) cells are crucial innate immune cells with antitumour and antiviral functions.
• Clinical application of NK cells is limited by challenges in enhancing their antitumour efficacy.
• Existing methods for augmenting NK cell function are insufficient for robust clinical translation.

Purpose of the Study:

• To develop a novel method for generating potent NK cells with augmented antitumour functions.
• To characterize the molecular mechanisms underlying the enhanced functions of these modified NK cells.
• To establish a scalable approach for producing clinical-grade NK cells.

Main Methods:

• Co-culture of human NK cells with osteoclasts in the presence of probiotic bacteria.
• Comprehensive analysis including proteomics, transcriptomics, flow cytometry, and cytotoxicity assays.
• Assessment of cell motility, proliferation, and susceptibility to exhaustion.

Main Results:

• The novel co-culture method generated "supercharged" NK (sNK) cells with significantly enhanced cytotoxicity and polyfunctionality.
• sNK cells exhibited increased resistance to anergy and tumour-induced exhaustion.
• Proteomic and transcriptomic analyses revealed upregulated pathways related to cell motility, proliferation, and Granzyme B production.

Conclusions:

• This innovative method effectively generates potent sNK cells suitable for clinical applications.
• The study elucidates key molecular mechanisms, including STAT1 and MYC activation, driving enhanced NK cell effector functions.
• The findings pave the way for improved immunotherapies leveraging augmented NK cell activity.